PHIOGEN, Baylor College of Medicine and LillixBio launch AI-driven collaboration to map phage-induced immunomodulation and long-term prevention
October 08, 2026
October 08, 2026
HOUSTON, Texas, Oct. 8 -- The Baylor College of Medicine posted the following news:
* * *
PHIOGEN, Baylor College of Medicine and LillixBio launch AI-driven collaboration to map phage-induced immunomodulation and long-term prevention
*
Baylor College of Medicine is collaborating with Phiogen Inc., a pre-clinical-stage biopharma company developing bacteriophages as first-in-class immunizing therapeutics, and LillixBio LLC, a global therapeutic d . . .
* * *
PHIOGEN, Baylor College of Medicine and LillixBio launch AI-driven collaboration to map phage-induced immunomodulation and long-term prevention
*
Baylor College of Medicine is collaborating with Phiogen Inc., a pre-clinical-stage biopharma company developing bacteriophages as first-in-class immunizing therapeutics, and LillixBio LLC, a global therapeutic d . . .